NEWS BY TAG: Biotechnology Subscribe
In Memoriam: Frank Baldino, Jr., Ph.D.
The Ben Franklin Technology Partners are truly saddened by the loss of Frank Baldino, Jr., Ph.D.–founder, chairman and CEO of Cephalon, Inc. Read More...
OraSure Changes the Landscape of the Diagnostic Medical Testing Market
OraSure Technologies has changed the landscape in diagnostic medical testing. Its noninvasive oral test for HIV—the first approved by the FDA—has been lauded as a key tool in the fight against AIDS. OraSure's products have a variety of diagnostic capabilities, ranging from HIV to other Read More...
Morphotek’s Immune System Technology Spells Steady Growth
Sometimes the best defense is a good offense—a philosophy that lies at the core of Morphotek’s medical research and products. Morphotek develops antibodies that help the body’s own immune system fight cancer and inflammatory and infectious diseases. Morphotek develops antibodies that help the body's own immune Read More...
Forum for Regenerative Medicine Companies Seeking Capital to Be Held April 2010
The April 2010 Translational Forum is the only regenerative medicine conference globally that features investor funding and business model panels followed by a venture forum designed specifically for industry. Additionally, the Translational Forum will include participation from executives from more than 30 companies that have Read More...
BFTP SEP Board Member Wins Prestigious Award
Pennsylvania Bio plans to honor Brenda D. Gavin, a partner at Philadelphia-based Quaker BioVentures, with its Hubert J.P. Schoemaker Leadership Award at its 2010 annual dinner and awards celebration on March 11 at the Pennsylvania Convention Center in Philadelphia. Brenda Gavin, partner at Philadelphia-based Quaker Read More...
Morphotek Inc. Enters into a License Agreement with Centocor Ortho Biotech Inc.
Two Ben Franklin Alums Enter into Licensing Agreement Morphotek Inc. entered into a license agreement Wednesday with Centocor Ortho Biotech Inc. covering the development and commercialization of an antibody that targets a specific antigen that is over-expressed in cancer patients with a variety of solid Read More...
Cohera Medical Solidifies Funding Round, Looks Ahead to New Testing Phase
Patrick Daly, president and CEO of Cohera Medical, has led the company to a major funding round and developed plans for initial human testing on a biodegradable adhesive for plastic surgery procedures. It’s been an eventful couple of months for Patrick Daly and his team Read More...
Pennsylvania Biotechnology Center: Defining a New Way to Nurture Innovation
Dr. Timothy Block and his colleagues are defining a new way of nurturing innovation at the Pennsylvania Biotechnology Center of Bucks County, a hub of research and entrepreneurship. The PA Biotech Center recently received an $815,000 grant from the U.S. Economic Development Administration (EDA) to Read More...
Immunicon: Sharpening the Focus on Cancer Diagnostics
In the complicated world of cancer diagnosis, bigger is definitely not better. Recognizing the power of small, one company—Immunicon—has developed a technique that can isolate testing down to a single cell in a tube of blood-utilizing nanotechnology. CellTracks Analyzer II, part of Immunicon’s suite Read More...
PhenoTech: Delivering a More Accurate Blood-Typing Technology
Ask people what their blood type is and they’ll respond with O, A, B, or AB, followed by a positive or negative. Ask Guy Maestre, and you’ll get a very different story. Turns out that beyond these basics, humans have about 450 different blood types, Read More...
